Organisatie
Immunologie & Infectie
Huidige onderzoekers
31 - 40 of 106 results
- Ibrahim HAMAD (Lid)
- Niels HELLINGS (Lid)
- Jerome HENDRIKS (Lid)
- Doryssa HERMANS (Lid)
- Brenda HERNANDEZ BULNES (Lid)
- Leen HEYENS (Lid)
- Cindy HOEKS (Lid)
- Janne KAES (Lid)
- Hamza KHAN (Lid)
- Markus KLEINEWIETFELD (Lid)
Publicaties
1 - 10 van 408
- Recombinant arginase-1 and TIMP-1 as therapeutic options for spinal cord injury(2022)
Auteurs: Celine ERENS, Sven HENDRIX
Aantal pagina's: 215 - Fatty Acid Metabolism in Control of Immune Cell Function in Multiple Sclerosis(2021)
Auteurs: Elien GRAJCHEN, Jerome HENDRIKS
Aantal pagina's: 234 - Pulsed Thermal Method for Monitoring Cell Proliferation in Real-Time(2021)
Auteurs: Seppe BORMANS, Gilles OUDEBROUCKX, Patrick VANDORMAEL, Thijs VANDENRYT, Patrick WAGNER, Veerle SOMERS, Ronald THOELEN
- Fertility preservation counselling for women with endometriosis: a European online survey(2023)
Auteurs: Nicole Saenger, Marco Menabrito, Attilio Di Spiezo Sardo, Josep Estadella, Jasper VERGUTS
Pagina's: 73 - 85 - Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders(2021)
Auteurs: R Houghton, Joop VAN DEN BERGH, K Law, YT Liu, F de Vries
Pagina's: 1800 - 1814 - Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group(2022)
Auteurs: I Vergote, E Van Nieuwenhuysen, S De Waele, C Vulsteke, C Lamot, H Van den Bulck, Nele CLAES, MP Graas, Guy DEBROCK, I Spoormans, et al.
Pagina's: 753 - 760 - The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis(2021)
Auteurs: N. Li, M. Hiligsmann, A. Boonen, M. M. van Oostwaard, R. T. A. L. de Bot, C. E. Wyers, S. P. G. Bours, Joop VAN DEN BERGH
Pagina's: 1517 - 1530 - Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial(2023)
Auteurs: Byoung Chul Cho, Jong Seok Lee, Yi-Long Wu, Irfan Cicin, Manuel Cobo Dols, Myung-Ju Ahn, Kristof CUPPENS, Remi Veillon, Ernest Nadal, Josiane Mourao Dias, et al.
Pagina's: 1731 - 1742 - A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies(2020)
Auteurs: Annelie MONNIER, Evelina Tacconelli, Christine Årdal, Marco Cavaleri, Inge GYSSENS
- Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-sma...(2022)
Auteurs: J. F. Vansteenkiste, I. Demedts, E. Pons-Tostivint, B. Biesma, F. Borm, B. Colinet, Kristof CUPPENS, S. Derijcke, L. Greillier, J. Juergens, et al.
Pagina's: S1086